Abbott RT-PCR Molecular test: Abbott’s COVID-19 SARS-COV-2 was granted EAU by USFDA. The COVID-19 SARS-CoV-2 assay is based on Multiplex RT-PCR technology which can be used on the m2000 system, 64 of which are already installed across India in government centers under the National AIDS Control (NACO) HIV Viral Load testing program. Abbott will start India supplies towards the 3rd week of April.
Antibody rapid lateral flow test: Abbott has developed the Antibody Rapid test for CoVid-19 which can meet the current requirement of screening/testing of individuals for CoVid-19. These antibody tests can be conducted by lab technicians in the remote setting by using whole blood/serum/plasma and results in 15 minutes (Qualitative Yes/No). Abbott will be supplying the products to the Indian market towards the end of April 20, 2020.